Sequences of GLP-1, glucagon, GIP, OXM, and clinically available GLP-1... | Download Scientific Diagram
Peptide sequences and molecular structures of FDA approved GLP-1 RAs. | Download Scientific Diagram
Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology - Brandt - 2018 - Journal of Internal Medicine - Wiley Online Library
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes | Pharmacological Reviews
Newer GLP-1 receptor agonists and obesity-diabetes - ScienceDirect
Amino acid sequence alignment of GLP-1 and its family peptides. Amino... | Download Scientific Diagram
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
Amino Acid Structure of Native Human GLP-1 and Liraglutide. | Download Scientific Diagram
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist - ScienceDirect
New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs - Chen Gilor, Adam J Rudinsky, Melanie J Hall, 2016
Molecular interaction between GLP-1 and GLP1R. The amino acid sequences... | Download Scientific Diagram
Liraglutide, a once-daily human GLP-1 analogue | Semantic Scholar
Amino acid sequence alignment of GLP-1 and its family peptides. Amino... | Download Scientific Diagram
GLP-1 (1-37) (human, rat), Glucagon-like peptide analog (CAS 87805-34-3) (ab142024)
Frontiers | Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
GLP-1 RA Mechanism of Action | Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg
Amino acid sequence of glucagon like peptide-1 (GLP-1) and GLP-1... | Download Scientific Diagram
Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease | Molecular Pharmaceutics
EP1408050A1 - A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue - Google Patents
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes | Gene Therapy
IJMS | Free Full-Text | A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease | Scientific Reports
Amino acid sequences of the incretin hormones GLP-1 (glucagon-like... | Download Scientific Diagram
Design of modified mature human GLP-1 (mGLP-1). The amino acid sequence... | Download Scientific Diagram
